Muscarinic modulation of synaptic transmission via endocannabinoid signalling in the rat midbrain periaqueductal gray

Molecular Pharmacology

Volumn 74, Issue 5, 2008, Pages 1392-1398

  Lau, Benjamin K ^a   Vaughan, Christopher W ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 3,6A,11,14 TETRAHYDRO 9 METHOXY 2 METHYL 12H ISOQUINO[1,2 B]PYRROLO[3,2 F][1,3]BENZOXAZINE 1 CARBOXYLIC ACID ETHYL ESTER; 4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ATROPINE; CANNABINOID 1 RECEPTOR; CARBACHOL; ENDOCANNABINOID; GALLAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; PHYSOSTIGMINE; PIRENZEPINE; TETRAHYDROLIPSTATIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; GABAERGIC TRANSMISSION; MALE; MESENCEPHALON; NEUROPHARMACOLOGY; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ACETYLCHOLINE; ANIMALS; ENDOCANNABINOIDS; FEMALE; GAMMA-AMINOBUTYRIC ACID; MALE; MUSCARINIC ANTAGONISTS; PERIAQUEDUCTAL GRAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 54349116152     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.045872     Document Type: Article

References (36)

1. Aubert I, Cécyre D, Gauthier S, and Quirion R (1996) Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain. J Comp Neurol 369:31-55.
2. Behrends JC and ten Bruggencate G (1993) Cholinergic modulation of synaptic inhibition in the guinea pig hippocampus in vitro: excitation of GABAergic interneurons and inhibition of GABA-release. J Neurophysiol 69:626-629.
3. Bellingham MC and Berger AJ (1996) Presynaptic depression of excitatory synaptic inputs to rat hypoglossal motoneurons by muscarinic M2 receptors. J Neurophysiol 76:3758-3770.
4. Best AR and Regehr WG (2008) Serotonin evokes endocannabinoid release and retrogradely suppresses excitatory synapses. J Neurosci 28:6508-6515.
5. Caulfield MP (1993) Muscarinic receptors - characterization, coupling and function. Pharmacol Ther 58:319-379.
6. Chevaleyre V, Takahashi KA, and Castillo PE (2006) Endocannabinoid- mediated synaptic plasticity in the CNS. Annu Rev Neurosci 29:37-76.
7. Drew GM, Mitchell VA, and Vaughan CW (2008) Glutamate spillover modulates GABAergic synaptic transmission in the rat midbrain periaqueductal grey via metabotropic glutamate receptors and endocannabinoid signaling. J Neurosci 28:808-815.
8. Fields HL, Basbaum AI, and Heinricher MM (2006) Central nervous systems mechanisms of pain modulation, in Textbook of Pain (McMahon SB and Koltzenburg M eds) pp 125-142, Elsevier, Churchill Livingston, Philadelphia, PA.
9. Finn DP, Jhaveri MD, Beckett SR, Roe CH, Kendall DA, Marsden CA, and Chapman V (2003) Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats. Neuropharmacology 45:594-604.
10. Fukudome Y, Ohno-Shosaku T, Matsui M, Omori Y, Fukaya M, Tsubokawa H, Taketo MM, Watanabe M, Manabe T, and Kano M (2004) Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M-2-mediated direct suppression and M-1/M-3-mediated indirect suppression through endocannabinoid signalling. Eur J Neurosci 19:2682-2692.
11. Guimarães AP, Guimarães FS, and Prado WA (2000) Modulation of carbachol-induced antinociception from the rat periaqueductal gray. Brain Res Bull 51:471-478.
12. Hashimotodani Y, Ohno-Shosaku T, and Kano M (2007) Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus. J Neurosci 27:1211-1219.
13. 2+ dependency for triggering retrograde endocannabinoid signal. Neuron 45:257-268.
14. Hohmann AG, Suplita RL, Bolton NM, Neely MH, Fegley D, Mangieri R, Krey JF, Walker JM, Holmes PV, Crystal JD, et al. (2005) An endocannabinoid mechanism for stress-induced analgesia. Nature 435:1108-1112.
15. Kathuria S, Gaetani S, Fegley D, Valiño F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, et al. (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9:76-81.
16. Keay KA and Bandler R (2001) Parallel circuits mediating distinct emotional coping reactions to different types of stress. Neurosci Biobehav Rev 25:669-678.
17. Kim J, Isokawa M, Ledent C, and Alger BE (2002) Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J Neurosci 22:10182-10191.
18. Lewis JW, Cannon JT, and Liebeskind JC (1980) Opioid and nonopioid mechanisms of stress analgesia. Science 208:623-625.
19. Li F, Endo T, and Isa T (2004) Presynaptic muscarinic acetylcholine receptors suppress GABAergic synaptic transmission in the intermediate grey layer of mouse superior colliculus. Eur J Neurosci 20:2079-2088.
20. Lichtman AH, Cook SA, and Martin BR (1996) Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement. J Pharmacol Exp Ther 276:585-593.
21. 2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase C beta 4 signaling cascade in the cerebellum. J Neurosci 25:6826-6835.
22. Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, and Gessa GL (2004) Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci 24:53-62.
23. Monassi CR, Hoffmann A, and Menescal-de-Oliveira L (1997) Involvement of the cholinergic system and periaqueductal gray matter in the modulation of tonic immobility in the guinea pig. Physiol Behav 62:53-59.
24. Monassi CR, Leite-Panissi CR, and Menescal-de-Oliveira L (1999) Ventrolateral periaqueductal gray matter and the control of tonic immobility. Brain Res Bull 50:201-208.
25. Moreira FA, Aguiar DC, and Guimarães FS (2007) Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray. Neuropharmacology 52:958-965.
26. Narushima M, Hashimoto K, and Kano M (2006) Endocannabinoid-mediated short-term suppression of excitatory synaptic transmission to medium spiny neurons in the striatum. Neurosci Res 54:159-164.
27. Narushima M, Uchigashima M, Fukaya M, Matsui M, Manabe T, Hashimoto K, Watanabe M, and Kano M (2007) Tonic enhancement of endocannabinoid-mediated retrograde suppression of inhibition by cholinergic interneuron activity in the striatum. J Neurosci 27:496-506.
28. Newman Z, Malik P, Wu TY, Ochoa C, Watsa N, and Lindgren C (2007) Endocannabinoids mediate muscarine-induced synaptic depression at the vertebrate neuromuscular junction. Eur J Neurosci 25:1619-1630.
29. Ohno-Shosaku T, Matsui M, Fukudome Y, Shosaku J, Tsubokawa H, Taketo MM, Manabe T, and Kano M (2003) Postsynaptic M-1 and M-3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus. Eur J Neurosci 18:109-116.
30. Pacher P, Bátkai S, and Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58:389-462.
31. Shen KZ and Johnson SW (2000) Presynaptic dopamine D-2 and muscarine M-3 receptors inhibit excitatory and inhibitory transmission to rat subthalamic neurones in vitro. J Physiol 525:331-341.
32. Uchigashima M, Narushima M, Fukaya M, Katona I, Kano M, and Watanabe M (2007) Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J Neurosci 27:3663-3676.
33. Vaughan CW, Connor M, Bagley EE, and Christie MJ (2000) Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro. Mol Pharmacol 57:288-295.
34. Vaughan CW, Ingram SL, Connor MA, and Christie MJ (1997) How opioids inhibit GABA-mediated neurotransmission. Nature 390:611-614.
35. Woolf NJ, Harrison JB, and Buchwald JS (1990) Cholinergic neurons of the feline pontomesencephalon. II. Ascending anatomical projections. Brain Res 520:55-72.
36. Yasuda RP, Ciesla W, Flores LR, Wall SJ, Li M, Satkus SA, Weisstein JS, Spagnola BV, and Wolfe BB (1993) Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain. Mol Pharmacol 43:149-157.